Federal Register / Vol. 65, No. 97 / Thursday, May 18, 2000 / Notices 31579

Assay for the Detection of a Variety of

Tumors in Biological Specimens

Larry W. Fisher, Neal S. Fedarko,

Marian F. Young (NICHD)

DHHS Reference No. E–173–98/0 filed

09 Apr 1999

The inventors have developed

methods and reagents for the detection

of bone sialoprotein (BSP) in biological

samples. The technology relates to the

disruption of a serum complex that

masks the majority of BSP from

established detection systems.

Furthermore, there is evidence that

there may be a more acidic form of BSP

secreted not by normal bone, but only

by tumors. Detection of BSP in serum

may be a good marker of various bone

diseases and a variety of cancers

including breast, prostate, lung, and

thyroid.

Dated: April 25, 2000.

Jack Spiegel,

Director, Division of Technology Development

and Transfer, Office of Technology Transfer,

National Institutes of Health.

[FR Doc. 00–12547 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Complementary &

Alternative Medicine; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Complementary and Alternative Medicine

Special Emphasis Panel.

Date: June 5–7, 2000.

Time: 8:30 am to 1:00 pm.

Agenda: To review and evaluate grant

applications.

Place: 6001 Executive Blvd., Room A1/A2,

Rockville, MD 20852.

Contact Person: Eugene G. Hayunga, PhD,

Scientific Review Administrator, National

Institutes of Health, NCCAM, Building 31,

Room 5B50, 9000 Rockville Pike, Bethesda,

MD 20892, 301–594–2014,

hayungae@od.nih.gov.

Dated: May 4, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12544 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed meetings.

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel.

Date: June 14, 2000.

Time: 8:30 am to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Louise P. Corman, PhD,

Scientific Review Administrator, Review

Branch, NIH, NHLBI, Rockledge Building II,

6701 Rockledge Drive, Suite 7180, Bethesda,

MD 20892–7924, (301) 435–0270.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel,

Clinical Trials Special Emphasis Panel.

Date: June 27, 2000.

Time: 8 am to 1 pm.

Agenda: To review and evaluate grant

applications.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Joyce A. Hunter, National

Heart, Lung, and Blood Inst., NIH, Rockledge

Center, II, 6701 Rockledge Drive, Suite 7194,

Bethesda, MD 20892–7924, 301/435–0288.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel.

Date: July 13, 2000.

Time: 9 am to 3:30 pm.

Agenda: To review and evaluate grant

applications.

Place: Hilton National Airport Hotel, 2399

Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Louise P. Corman, PhD,

Scientific Review Administrator, Review

Branch, NIH, NHLBI, Rockledge Building II,

6701 Rockledge Drive, Suite 7180, Bethesda,

MD 20892–7924, (301) 435–0270.

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel.

Date: July 14, 2000.

Time: 9 am to 12:30 pm.

Agenda: To review and evaluate grant

applications.

Place: Washington National Airport Hilton,

2399 Jefferson Davis Highway, Arlington, VA

22202.

Contact Person: Louise P. Corman, PhD,

Scientific Review, Administrator, Review

Branch, NIH, NHLBI, Rockledge Building II,

6701 Rockledge Drive, Suite 7180, Bethesda,

MD 20892–7924, (301) 435–0270.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: May 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Fedeal Advisory Committee

Policy.

[FR Doc. 00–12543 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date: June 15, 2000.

Time: 4 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn, Bethesda, MD 20814.

Contact Person: Elsie D. Taylor, Scientific

Review Administrator, Extramural Project

Review Branch, National Institute of Alcohol

31580 Federal Register / Vol. 65, No. 97 / Thursday, May 18, 2000 / Notices

Abuse and Alcoholism National Institutes of

Health, Suite 409, 6000 Executive Blvd.

Bethesda, MD 20892–7003, 301–443–9787,

etaylor@niaaa.nih.gov

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Program;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: May 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12532 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

such as patentable material, and

personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date: June 6, 2000.

Time: 7 am to 8 am.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20914.

Contact Person: Ronald Suddendorf, Phd,

Scientific Review Administrator, Extramural

Project Review Branch, National Institute on

Alcohol Abuse and Alcoholism, National

Institutes of Health, Suite 409, 6000

Executive Boulevard, Bethesda, MD 20892–

7003, 301–443–2926.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: May 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12533 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

application, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Acquired

Immunodeficiency Syndrome Research

Review Committee.

Date: June 15–16, 2000.

Time: 8:30 am to 5 pm.

Agenda: To review and evaluate grant

applications.

Place: The Governor’s House Hotel,

Cabinet Room, 1615 Rhode Island Avenue,

NW, Washington, DC 20036.

Contact Person: Paula S. Strickland, Phd,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2156, 6700–B

Rockledge Drive, MSC 7610, Bethesda, MD

20892–7610, 301–496–2550.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: May 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12534 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Communication

Disorders Review Committee.

Date: June 14, 2000.

Time: 8 am to 6 pm.

Agenda: To review and evaluate grant

applications.

Place: Latham Hotel, 3000 M Street, NW.,

Washington, DC 20007–3701.

Contact Person: Melissa Stick, PhD, MPH,

Scientific Review Administrator, Scientific

Review Branch, Division of Extramural

Research, NIDCD/NIH, 6120 Executive Blvd.,

Bethesda, MD 20892, 301–496–8683.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.173, Biological Research

Related to Deafness and Communicative

Disorders, National Institutes of Health, HHS)

Dated: May 10, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12535 Filed 5–17–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections